Skip to main content
Clinical Trials/IRCT20220509054793N1
IRCT20220509054793N1
Recruiting
Phase 1

A clinical trial to compare the effectiveness of the Spirulina platensis algae (Arthrospira, blue-green algae) and N-acetyl cysteine with standard treatment in patients with COVID-19 infection

Mashhad University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Mashhad University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with COVID\-19 infection base on clinical manifestations, chest CT scan and PCR test results
  • Age over 18 years
  • The oxygen saturation of patient is 85 percent or greater at rest

Exclusion Criteria

  • having chronic lung disease
  • Pregnant women
  • Having autoimmune disease
  • History of allergy to the seaweed or its derivatives
  • History of bronchospasm after using of N\-acetylcysteine
  • Having chronic liver disease
  • History of phenylketonuria
  • Having bleeding (Massive hemoptysis, gastrointestinal bleeding, epistaxis, purpura, ecchymosis)
  • Neutrophil count of less than 500 mmc
  • A platelet count of less than 2000 mmc

Outcomes

Primary Outcomes

Not specified

Similar Trials